Bristol Myers Squibb has unveiled a $1.8m initiative to advance health equity by addressing social determinants of health (SDoH) in four countries with underserved patient needs, including the United Kingdom, Brazil, India, and Thailand.
The new health equity grants are an extension of our broader long-term commitment to invest $150m in health equity by 2025.